McCleary Joel 4
4 · PHARMATHENE, INC · Filed Nov 5, 2010
Insider Transaction Report
Form 4
McCleary Joel
Director
Transactions
- Conversion
Common Stock
2010-11-03$2.54/sh+18,757$47,675→ 120,167 total - Conversion
10% Convertible Note
2010-11-03→ 0 totalExercise: $2.54Exp: 2011-07-28→ Common Stock (18,757 underlying)
Footnotes (3)
- [F1]The 10% Convertible Note (the "Note") including accrued interest thereon, was convertible into the Issuer's Common Stock at a price of $2.541667 per share.
- [F2]Immediately.
- [F3]This Note together with a Warrant was received pursuant to a Note and Warrant Purchase Agreement dated as of July 24, 2009, as amended on July 26, 2009 and July 28, 2009, by and among the Issuer and certain noteholders, all as more specifically reported on Form 4 filed with the Securities & Exchange Commission on July 30, 2009.